Tessa DesRochers

Company: Kiyatec

Job title: Chief Scientific Officer

Seminars:

Ex Vivo Tumor Models for Drug Development and Clinical Testing 4:15 pm

• Understanding Kiyatec’s different ex vivo platforms • Application of ex vivo models throughout drug development, including immuno-oncology • Correlating ex vivo response to in vivo response in XPDX and the clinicRead more

day: Day One

Patient-Derived Tumor Models 4:45 pm

• Highlighting the different preclinical tumor models in use • Reviewing the reasons and context for use • Determining analysis strategies for combination efficacy and safetyRead more

day: Day One Track B PM 2